These findings demonstrate that super-resolution imaging of ANGPTL4 and nephrin is a powerful clinical tool for assessing damage to the glomerular filtration barrier, highlighting the distinct pathological podocyte injury patterns in FSGS patients, who show more severe damage than MCD patients do, despite their similar clinical presentations. The gene discussed is NPHS1; the disease is focal segmental glomerulosclerosis.